Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
|Articles|February 1, 2004
How to recognize and manage herpes simplex virus type 1 infections
Herpes simplex infection is often misdiagnosed. Here is a look at distinguishing features of type 1 infections and a review of associated disorders, diagnostic tools, and treatment options.
Advertisement
Advertisement
Related to this article
Hai D. Nguyen-Tran, MD, discusses clinical signs, neurologic warning symptoms, supportive care, and preventing the spread of hand, foot, and mouth disease.
Topical botanical Cinainu earned FDA Breakthrough Therapy status for AA in patients aged 2+, supported by phase 2/3 RAAINBOW data in children.
Real-world claims show dupilumab was tied to a 33%-52% lower risk of atopic march progression vs systemic corticosteroids in children with AD.
Once-daily roflumilast cream 0.05% was well tolerated in infants 3 to <24 months with AD, with 34.4% reaching vIGA-AD success at week 4.
Oral icotrokinra kept PASI 90 rates at ≥72% and IGA 0/1 at ≥70% from week 64 to 112 in ICONIC-LEAD, with no new safety signals.
Diana F. Clarke, PharmD, explains how IMPAACT 2023 supported dolutegravir from birth, plus dosing tips and open questions for preterm infants.
At AAP 2026, Peter Lio, MD, discussed distinguishing allergic and inflammatory skin conditions and when pediatricians should seek specialty care.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA sets new PDUFA date for Anaphylm for type I allergic reactions
2
Youth-onset type 2 diabetes may progress faster, signs easy to miss
3
When one young athlete’s cardiac arrest revealed a family at risk
4
SUID drives widening Black-White infant mortality gap since 2020
5